Etrasimod
Etrasimod (APD334) is a potent and selective oral S1P1 receptor antagonist, with an IC50 of 1.88 nM in CHO cells. It is a valuable research tool for investigating S1P1 signaling in autoimmune and inflammatory disease models, both in vitro and in vivo.
Product Specifications
CAS Number
1206123-37-6
Product Name Alternative
APD334, APD-334, APD 334, Inhibitor, Etrasimod, inhibit, LPL Receptor, LPLReceptor, LPL, Lysophospholipid Receptor, S1P Receptor, S1P1, S1PReceptor
Field of Research
Pharmacology & Drug Discovery
Purity
98.52% (May vary between batches)
Solubility
DMSO:25 mg/mL (54.65 mM)
Smiles
OC (=O) C[C@H]1CCc2c1[nH]c1ccc (OCc3ccc (C4CCCC4) c (c3) C (F) (F) F) cc21
Molecular Formula
C26H26F3NO3
Molecular Weight
457.48
Storage Conditions
Store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HRP-Linked Polyclonal Antibody to Myoglobin (MYO)
HRP-Linked Polyclonal Antibody to Myoglobin (MYO)
HRP-Linked Polyclonal Antibody to Myoglobin (MYO)
HRP-Linked Polyclonal Antibody to Myoglobin (MYO)
HRP-Linked Polyclonal Antibody to Myoglobin (MYO)